Neuland Laboratories Financial Statements
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar | Mar-2020 | Mar-2019 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
| Growth matrix (%) | ||||
| Revenue growth | 14.40 | 26.40 | (8.90) | 13.50 |
| Op profit growth | 74.60 | 15.70 | (53) | 32.20 |
| EBIT growth | 107 | 9.55 | (63) | 32.80 |
| Net profit growth | (1.40) | 36.30 | (74) | 71.50 |
| Profitability ratios (%) | ||||
| OPM | 13.40 | 8.75 | 9.56 | 18.40 |
| EBIT margin | 9.77 | 5.40 | 6.23 | 15.20 |
| Net profit margin | 2.13 | 2.47 | 2.29 | 8.10 |
| RoCE | 7.28 | 3.69 | 3.81 | 15.10 |
| RoNW | 0.58 | 0.65 | 0.55 | 3.20 |
| RoA | 0.40 | 0.42 | 0.35 | 2 |
| Per share ratios () | ||||
| EPS | 12.60 | 12.70 | 13.50 | 52.30 |
| Dividend per share | 2 | -- | -- | -- |
| Cash EPS | (12) | (7.30) | (11) | 30.90 |
| Book value per share | 550 | 542 | 623 | 609 |
| Valuation ratios | ||||
| P/E | 22.50 | 52.90 | 52.50 | 28.40 |
| P/CEPS | (24) | (92) | (63) | 48.20 |
| P/B | 0.52 | 1.24 | 1.13 | 2.44 |
| EV/EBIDTA | 5.45 | 17.10 | 16.90 | 14 |
| Payout (%) | ||||
| Dividend payout | -- | -- | -- | -- |
| Tax payout | (69) | (19) | (13) | (30) |
| Liquidity ratios | ||||
| Debtor days | 84.70 | 98 | 130 | 94.60 |
| Inventory days | 98.60 | 101 | 107 | 82.50 |
| Creditor days | (69) | (77) | (84) | (71) |
| Leverage ratios | ||||
| Interest coverage | (3.50) | (2.30) | (1.70) | (4.20) |
| Net debt / equity | 0.30 | 0.28 | 0.54 | 0.33 |
| Net debt / op. profit | 2.09 | 3.32 | 5.99 | 1.69 |
| Cost breakup () | ||||
| Material costs | (50) | (55) | (45) | (45) |
| Employee costs | (16) | (17) | (20) | (16) |
| Other costs | (21) | (20) | (26) | (20) |
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar( In .Cr) | Mar-2020 | Mar-2019 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
| Revenue | 763 | 667 | 527 | 579 |
| yoy growth (%) | 14.40 | 26.40 | (8.90) | 13.50 |
| Raw materials | (380) | (366) | (238) | (263) |
| As % of sales | 49.80 | 54.90 | 45.20 | 45.40 |
| Employee costs | (124) | (110) | (103) | (93) |
| As % of sales | 16.20 | 16.60 | 19.50 | 16 |
| Other costs | (157) | (132) | (136) | (117) |
| As % of sales | 20.60 | 19.80 | 25.70 | 20.20 |
| Operating profit | 102 | 58.40 | 50.40 | 106 |
| OPM | 13.40 | 8.75 | 9.56 | 18.40 |
| Depreciation | (31) | (26) | (22) | (19) |
| Interest expense | (22) | (16) | (19) | (21) |
| Other income | 3.89 | 3.49 | 4.53 | 1.17 |
| Profit before tax | 52.90 | 20.30 | 13.90 | 67.20 |
| Taxes | (37) | (3.90) | (1.90) | (20) |
| Tax rate | (69) | (19) | (13) | (30) |
| Minorities and other | -- | -- | -- | -- |
| Adj. profit | 16.20 | 16.40 | 12.10 | 46.90 |
| Exceptional items | -- | -- | -- | -- |
| Net profit | 16.20 | 16.40 | 12.10 | 46.90 |
| yoy growth (%) | (1.40) | 36.30 | (74) | 71.50 |
| NPM | 2.13 | 2.47 | 2.29 | 8.10 |
- Switch to
-
Tabular DataGraph
| Y/e 31 Mar ( In .Cr) | Mar-2020 | Mar-2019 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
| Profit before tax | 52.90 | 20.30 | 13.90 | 67.20 |
| Depreciation | (31) | (26) | (22) | (19) |
| Tax paid | (37) | (3.90) | (1.90) | (20) |
| Working capital | 231 | 193 | 165 | 107 |
| Other operating items | -- | -- | -- | -- |
| Operating cashflow | 216 | 184 | 155 | 135 |
| Capital expenditure | 498 | 351 | 263 | 226 |
| Free cash flow | 714 | 535 | 417 | 361 |
| Equity raised | 756 | 748 | 630 | 607 |
| Investments | 0.47 | 0.51 | 0.54 | 0.52 |
| Debt financing/disposal | 34.20 | 21.90 | 165 | 58 |
| Dividends paid | -- | -- | -- | -- |
| Other items | -- | -- | -- | -- |
| Net in cash | 1,505 | 1,305 | 1,213 | 1,027 |
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar ( In .Cr) | Mar-2020 | Mar-2019 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
| Equity capital | 12.90 | 12.90 | 8.95 | 8.95 |
| Preference capital | -- | -- | -- | -- |
| Reserves | 697 | 686 | 549 | 537 |
| Net worth | 710 | 699 | 558 | 546 |
| Minority interest | ||||
| Debt | 260 | 231 | 319 | 192 |
| Deferred tax liabilities (net) | 66.70 | 80.80 | 64.60 | 45.70 |
| Total liabilities | 1,036 | 1,012 | 942 | 783 |
| Fixed assets | 676 | 646 | 601 | 485 |
| Intangible assets | ||||
| Investments | 7.86 | 7.90 | 7.90 | 7.88 |
| Deferred tax asset (net) | 18.90 | 69.60 | 51.80 | 30.60 |
| Net working capital | 286 | 250 | 264 | 247 |
| Inventories | 220 | 193 | 175 | 135 |
| Inventory Days | 105 | 105 | 121 | 85.20 |
| Sundry debtors | 190 | 164 | 194 | 181 |
| Debtor days | 90.90 | 89.80 | 134 | 114 |
| Other current assets | 90.40 | 82 | 76.30 | 63.80 |
| Sundry creditors | (125) | (127) | (130) | (89) |
| Creditor days | 59.70 | 69.30 | 89.90 | 56.40 |
| Other current liabilities | (89) | (62) | (52) | (43) |
| Cash | 47 | 37.80 | 17.30 | 12.50 |
| Total assets | 1,036 | 1,012 | 942 | 783 |
- Switch to
-
ConsolidatedStandalone
| Particulars ( Rupees In Crores.) | Sep-2020 | Jun-2020 | Mar-2020 | Dec-2019 | Sep-2019 |
|---|---|---|---|---|---|
| Gross Sales | 241 | 205 | 192 | 204 | 186 |
| Excise Duty | -- | -- | -- | -- | -- |
| Net Sales | 241 | 205 | 192 | 204 | 186 |
| Other Operating Income | -- | -- | -- | -- | -- |
| Other Income | 0.61 | 0.70 | 1.78 | 1.02 | 0.57 |
| Total Income | 242 | 206 | 193 | 205 | 187 |
| Total Expenditure ** | 201 | 172 | 162 | 176 | 161 |
| PBIDT | 41.50 | 34.50 | 31.90 | 29.20 | 25.50 |
| Interest | 3.51 | 5.37 | 7.07 | 5.69 | 4.78 |
| PBDT | 38 | 29.20 | 24.80 | 23.50 | 20.70 |
| Depreciation | 9.27 | 8.86 | 7.63 | 7.82 | 8.28 |
| Minority Interest Before NP | -- | -- | -- | -- | -- |
| Tax | 3.48 | -- | (8.30) | 3.16 | 3.29 |
| Deferred Tax | 3.77 | 5.15 | 34.80 | 1.40 | 0.47 |
| Reported Profit After Tax | 21.40 | 15.20 | (9.30) | 11.10 | 8.69 |
| Minority Interest After NP | -- | -- | -- | -- | -- |
| Net Profit after Minority Interest | 21.40 | 15.20 | (9.30) | 11.10 | 8.69 |
| Extra-ordinary Items | -- | -- | -- | -- | -- |
| Adjusted Profit After Extra-ordinary item | 21.40 | 15.20 | (9.30) | 11.10 | 8.69 |
| EPS (Unit Curr.) | 16.70 | 11.80 | (7.30) | 8.66 | 6.77 |
| Book Value (Unit Curr.) | -- | -- | -- | -- | -- |
| Dividend (%) | 20 | -- | -- | 20 | -- |
| Equity | 12.90 | 12.90 | 12.90 | 12.90 | 12.90 |
| Public Shareholding (Number) | -- | -- | -- | -- | -- |
| Public Shareholding (%) | -- | -- | -- | -- | -- |
| Pledged/Encumbered - No. of Shares | -- | -- | -- | -- | -- |
| Pledged/Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | -- |
| Pledged/Encumbered - % in Total Equity | -- | -- | -- | -- | -- |
| Non Encumbered - No. of Shares | -- | -- | -- | -- | -- |
| Non Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | -- |
| Non Encumbered - % in Total Equity | -- | -- | -- | -- | -- |
| PBIDTM(%) | 17.20 | 16.80 | 16.70 | 14.30 | 13.70 |
| PBDTM(%) | 15.70 | 14.20 | 13 | 11.50 | 11.10 |
| PATM(%) | 8.88 | 7.38 | (4.90) | 5.45 | 4.67 |
